A case–control study of quadrivalent human papillomavirus vaccine-associated autoimmune adverse events

GARDASIL (Merck & Co., Inc., Whitehouse Station, NJ, USA) is a quadrivalent human papillomavirus (HPV4) vaccine. An epidemiological study was undertaken to evaluate concerns about the potential for HPV4 vaccination to induce serious autoimmune adverse events (SAAEs). The vaccine adverse event re...

Descripción completa

Detalles Bibliográficos
Autores principales: Geier, David A., Geier, Mark R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer London 2014
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4475239/
https://www.ncbi.nlm.nih.gov/pubmed/25535199
http://dx.doi.org/10.1007/s10067-014-2846-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4475239/
https://www.ncbi.nlm.nih.gov/pubmed/25535199
http://dx.doi.org/10.1007/s10067-014-2846-1

Ejemplares similares